The inactivation of the prototype NF-kappaB inhibitor, IkappaBalpha, occurs through a series of ordered processes including phosphorylation, ubiquitin conjugation and proteasome-mediated degradation (Ub-Pr). We have identified valosin-containing protein (VCP), an AAA (ATPases associated with a variety of cellular activities) family member, that co- precipitated with IkappaBalpha immune complexes. The ubiquitinated IkappaBalpha conjugates readily associated with VCP both in vivo and in vitro, and this complex was dissociated from NF-kappaB. Analyses of IkappaBalpha mutants indicated that phosphorylation and ubiquitination were critical for VCP binding which was required for degradation, and the N-terminal domain of IkappaBalpha was required in all three reactions. Density gradient centrifugation analysis showed that complexes containing physically associated VCP and ubiquitinated IkappaBalpha sedimented as 650 kDa molecules with a coefficient of 19S, while the unmodified IkappaBalpha sedimented in 4.5S fractions deficient in VCP. VCP antibodies depleted proteasome activity while immunopurified VCP complexes were sufficient to perform proteasome-like activity, further supporting that VCP is functionally involved in Ub-Pr mediated degradation of IkappaBalpha. VCP co-migrated with subunit 2 (S2) of the 26S proteasome on two dimensional (2D) gels, and was co-purified with S2 in a highly purified proteasome preparation. We propose a model for IkappaBalpha inactivation in which ubiquitinated IkappaBalpha conjugates become physically associated with VCP which displaces the NF-kappaB dimer, thus releasing the dimer for translocation into the nucleus. The ubiquitinated IkappaBalpha is then chaperoned to the 26S proteasome for degradation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC010029-01
Application #
2463824
Study Section
Large Bowel and Pancreatic Cancer Review Committee (LBP)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Wang, Qing; Song, Changcheng; Li, Chou-Chi H (2004) Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J Struct Biol 146:44-57
Yang, Yili; Li, Chou-Chi H; Weissman, Allan M (2004) Regulating the p53 system through ubiquitination. Oncogene 23:2096-106
Wang, Qing; Song, Changcheng; Yang, Xiaoyi et al. (2003) D1 ring is stable and nucleotide-independent, whereas D2 ring undergoes major conformational changes during the ATPase cycle of p97-VCP. J Biol Chem 278:32784-93
Wang, Qing; Song, Changcheng; Li, Chou-Chi H (2003) Hexamerization of p97-VCP is promoted by ATP binding to the D1 domain and required for ATPase and biological activities. Biochem Biophys Res Commun 300:253-60
Song, Changcheng; Wang, Qing; Li, Chou-Chi H (2003) ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity. J Biol Chem 278:3648-55